{"@context":"https://schema.org","@type":"Dataset","@id":"https://lunartuliplab.com/research/palantir-ai-application-commercialization-2026q2#dataset","name":"Palantir: Hard commercial proof, zero valuation slack","identifier":"RO-COMP-PLTR-001","version":"3.0.0","datePublished":"2026-08-05","dateModified":"2026-09-14","temporalCoverage":"..2026-09-14","publisher":{"@type":"Organization","@id":"https://lunartuliplab.com/#organization","name":"Lunartulip Lab"},"isPartOf":"https://lunartuliplab.com/research.json","usageNotice":"Public metadata is provided for discovery and citation. Publication does not grant a commercial data license. Research is not investment advice.","canonical":{"zh-CN":"https://lunartuliplab.com/deep-dive/palantir-ai-application-commercialization-2026q2","en":"https://lunartuliplab.com/en/deep-dive/palantir-ai-application-commercialization-2026q2"},"researchObject":{"id":"RO-COMP-PLTR-001","slug":"palantir-ai-application-commercialization-2026q2","kind":"company-deep-dive","tickers":["PLTR"],"publishedAt":"2026-08-05","asOf":"2026-09-14","version":"3.0.0","sourceLabel":"Palantir commercial budget migration · 2026-09-14 edition","claims":[{"id":"CL-PLTR-001","type":"Fact","text":{"zh-CN":"Palantir 2026 年第二季度收入 19.35464 亿美元，同比增长 93%；其中美国商业收入 7.64 亿美元，同比增长 149%。","en":"Palantir reported Q2 2026 revenue of $1.935464 billion, up 93% year over year, including U.S. commercial revenue of $764 million, up 149%."},"evidenceIds":["EV-PLTR-001"]},{"id":"CL-PLTR-002","type":"Fact","text":{"zh-CN":"美国商业 TCV bookings 为 21.32 亿美元，同比增长 153%；公司同时把 2026 年收入指引上调至 81.50–81.58 亿美元。TCV 计量的是合同承诺总额。","en":"U.S. commercial TCV bookings reached $2.132 billion, up 153%, and FY2026 revenue guidance was raised to $8.150–8.158 billion. TCV measures total contracted commitment."},"evidenceIds":["EV-PLTR-001"]},{"id":"CL-PLTR-003","type":"Derived","text":{"zh-CN":"按当季披露数计算，美国商业收入相当于美国政府收入的约 94%（7.64 亿 / 8.09 亿），商业预算已经构成第二条规模化收入来源。","en":"On the quarter's disclosed figures, U.S. commercial revenue equals roughly 94% of U.S. government revenue ($764m / $809m), making commercial budgets a second revenue base at scale."},"evidenceIds":["EV-PLTR-001"]},{"id":"CL-PLTR-004","type":"Hypothesis","text":{"zh-CN":"如果 bookings、TCV 与确认收入继续同步，说明企业客户已把 AIP 从试验预算迁进核心经营预算，高增长的久期会比单季增速所暗示的更长。公司没有按预算类别披露收入，这一条目前只能作为假设。","en":"If bookings, TCV and recognized revenue keep moving together, enterprise customers have shifted AIP from pilot spend into the core operating plan, and the duration of elevated growth would run longer than a single quarter's rate implies. Palantir discloses no revenue split by budget category, so this remains a hypothesis."},"evidenceIds":["EV-PLTR-001","EV-PLTR-002"]},{"id":"CL-PLTR-005","type":"Inference","text":{"zh-CN":"TTM P/S 约 65x、对 FY26 指引中点 forward P/S 约 49x 的定价把数年不降档写进前提；增速从 93% 降到 60% 仍属顶级增长，但倍数可能先于业绩重定价——9 月回撤已示范这一路径。","en":"Pricing at roughly 65× TTM sales and about 49× forward sales on the FY2026 guidance midpoint embeds years of non-decelerating growth; revenue growth falling from 93% to 60% would still be elite, yet the multiple can reprice ahead of earnings, as the September pullback demonstrated."},"evidenceIds":["EV-PLTR-001","EV-PLTR-003"]},{"id":"CL-PLTR-006","type":"Inference","text":{"zh-CN":"2026 年 9 月 11 日收盘 Palantir 股价 $167.23，市值约 $401.87B，较 52 周高点 $207.52 回撤约 19%；9 月 2 日单日收跌 5.8%，当日无负面公司公告。","en":"Palantir closed at $167.23 on September 11, 2026, with a market cap of about $401.87B, roughly 19% below the 52-week high of $207.52; on September 2 the stock fell 5.8% in a session with no negative company announcement."},"evidenceIds":["EV-PLTR-004"]},{"id":"CL-PLTR-007","type":"Fact","text":{"zh-CN":"2026 年 9 月 1 日美国陆军公告 TITAN 下一代移动情报节点量产合同总额 $192M，Palantir 作为主承包商获 $127M、Anduril 获 $65M，订单 2026 年 8 月 31 日生效。","en":"On September 1, 2026 the U.S. Army announced a $192M production award for the TITAN next-generation mobile intelligence node, with Palantir as prime contractor at $127M and Anduril at $65M, effective August 31, 2026."},"evidenceIds":["EV-PLTR-005"]}],"evidence":[{"id":"EV-PLTR-001","title":"Palantir Q2 2026 Business Update","source":{"publisher":"Palantir Investor Relations","url":"https://investors.palantir.com/files/Palantir%20-%20Q2%202026%20Business%20Update.pdf","document":"Q2 2026 Business Update"},"sourceDate":"2026-08-04","dataAsOf":"2026-06-30","calculation":null,"confidence":"high","counterevidence":"TCV is not revenue and may include multi-year commitments or timing effects.","lastVerified":"2026-08-15","role":"primary"},{"id":"EV-PLTR-002","title":"Palantir Q1 2026 Form 10-Q","source":{"publisher":"Palantir Investor Relations","url":"https://investors.palantir.com/files/2026%20Q1%20PLTR%2010-Q.pdf","document":"2026 Q1 Form 10-Q"},"sourceDate":"2026-05-06","dataAsOf":"2026-03-31","calculation":null,"confidence":"high","counterevidence":"Many customer contracts contain termination-for-convenience provisions.","lastVerified":"2026-08-15","role":"supporting"},{"id":"EV-PLTR-003","title":"Point-in-time valuation input gap","source":{"publisher":"LunarTulip Research","document":"Market-cap input intentionally withheld pending licensed point-in-time tape verification"},"sourceDate":"2026-08-05","dataAsOf":"2026-08-05","calculation":"Enterprise value scenarios are sensitivity outputs, not observed market value or price targets.","confidence":"low","counterevidence":"Without a verified point-in-time enterprise value, no observed forward-sales multiple is asserted.","lastVerified":"2026-08-15","role":"supporting"},{"id":"EV-PLTR-004","title":"MarketWatch PLTR quote snapshot","source":{"publisher":"MarketWatch","url":"https://www.marketwatch.com/investing/stock/pltr","document":"PLTR quote page"},"sourceDate":"2026-09-11","dataAsOf":"2026-09-11","calculation":null,"confidence":"high","counterevidence":"Third-party quote pages can differ on market cap and 52-week high by a few percent.","lastVerified":"2026-09-14","role":"primary"},{"id":"EV-PLTR-005","title":"Army TITAN production award","source":{"publisher":"Breaking Defense","url":"https://breakingdefense.com/2026/09/army-awards-192m-to-palantir-and-anduril-to-produce-titan-system/","document":"Army TITAN award coverage"},"sourceDate":"2026-09-02","dataAsOf":"2026-09-01","calculation":null,"confidence":"high","counterevidence":"Contract awards are not revenue until recognized under ASC 606.","lastVerified":"2026-09-14","role":"primary"}],"financialBridge":[{"label":{"zh-CN":"Q2 2026 收入","en":"Q2 2026 revenue"},"period":"2026-Q2","value":1935.464,"unit":"USDm","evidenceIds":["EV-PLTR-001"]},{"label":{"zh-CN":"美国商业收入","en":"U.S. commercial revenue"},"period":"2026-Q2","value":764,"unit":"USDm","evidenceIds":["EV-PLTR-001"]},{"label":{"zh-CN":"美国政府收入","en":"U.S. government revenue"},"period":"2026-Q2","value":809,"unit":"USDm","evidenceIds":["EV-PLTR-001"]},{"label":{"zh-CN":"FY2026 收入指引中点","en":"FY2026 revenue guidance midpoint"},"period":"2026-FY","value":8154,"unit":"USDm","evidenceIds":["EV-PLTR-001"]},{"label":{"zh-CN":"Q3 2026 营收指引中点","en":"Q3 2026 revenue guidance midpoint"},"period":"2026-Q3","value":2162,"unit":"USDm","evidenceIds":["EV-PLTR-001"]}],"valuationScenarios":[{"id":"VAL-PLTR-BASE","label":{"zh-CN":"增长延续","en":"Growth continues"},"revenueBaseUsdM":8154,"revenueGrowthPct":45,"forwardRevenueUsdM":11823.3,"salesMultiple":24,"impliedEnterpriseValueUsdM":283759.2,"calculation":"8154 * 1.45 = 11823.3; 11823.3 * 24 = 283759.2","interpretation":{"zh-CN":"以指引中点为基数，假设 45% 的远期增长和 24 倍 sales multiple，输出企业价值。当日 observed multiple 未经核验，24 倍是设定的假设，不构成对现价的比较。","en":"Takes the guidance midpoint, assumes 45% forward growth and a 24× sales multiple, and outputs enterprise value. With no verified point-in-time multiple, 24× is an assumption rather than a comparison against the tape."}},{"id":"VAL-PLTR-BEAR","label":{"zh-CN":"增长降档","en":"Growth resets"},"revenueBaseUsdM":8154,"revenueGrowthPct":25,"forwardRevenueUsdM":10192.5,"salesMultiple":14,"impliedEnterpriseValueUsdM":142695,"calculation":"8154 * 1.25 = 10192.5; 10192.5 * 14 = 142695","interpretation":{"zh-CN":"增长退到 25%、倍数退到 14 倍时，企业价值约为基准情景的一半。它说明定价对增长和倍数同时敏感，不映射每股价值。","en":"At 25% growth and a 14× multiple, enterprise value lands near half the base case. The point is joint sensitivity to growth and multiple; nothing here maps to per-share value."}}],"counterevidenceClaimIds":["CL-PLTR-005"],"falsifiers":[{"id":"FAL-PLTR-001","metric":"U.S. commercial revenue YoY growth","operator":"<","threshold":100,"unit":"percent","horizon":"any of the next two reported quarters","claimIds":["CL-PLTR-004"],"rationale":{"zh-CN":"美国商业增速在 Q3 跌破 +100% 是本文框架的第一降档信号；仍属高增速，但不足以支撑当前倍数对久期的要求。","en":"U.S. commercial growth below +100% in Q3 is the first downgrade signal in this framework; still fast in absolute terms, but insufficient for the duration embedded in the current multiple."}},{"id":"FAL-PLTR-002","metric":"U.S. commercial TCV bookings YoY growth","operator":"<","threshold":50,"unit":"percent","horizon":"any of the next two reported quarters","claimIds":["CL-PLTR-004"],"rationale":{"zh-CN":"TCV 是领先序列。它先跌破 50%，合同与确认收入的同步关系就断了，而这条同步关系是预算迁移命题的全部观察基础。","en":"TCV is the leading series. If it breaks below 50% first, the alignment between contracts and recognized revenue is gone, and that alignment is the entire observable basis for the budget-migration thesis."}}],"versions":[{"version":"1.0.0","date":"2026-08-05","diff":{"zh-CN":"原始时点判断：把 PLTR 读作 AI 应用层商业化的强正向样本。","en":"Original point-in-time view: PLTR read as a strong positive sample for AI application-layer monetization."}},{"version":"2.0.0","date":"2026-08-15","diff":{"zh-CN":"删掉错误的 10–12 倍 P/S、技术价位、仓位与 HYP 编号，换成第一方证据、可复算的情景算术和量化证伪条件。","en":"Removed the erroneous 10–12× sales multiple, technical levels, position sizing and the HYP identifier, replacing them with primary evidence, reproducible scenario arithmetic and quantitative falsifiers."}},{"version":"3.0.0","date":"2026-09-14","diff":{"zh-CN":"2026-09-14 更新：纳入 9 月估值回撤、TITAN 量产合同与 Q3 对账窗口；保留 v2 证据链并追加公开市场来源。","en":"September 14 update: adds the September valuation pullback, the TITAN production award and the Q3 reconciliation window while keeping the v2 evidence chain and adding public-market sources."}}],"renderings":{"zh-CN":{"locale":"zh-CN","siblingLocale":"en","title":"Palantir：商业化有硬数，定价零容错","question":"美国商业客户把 AIP 记在创新预算里，还是记在核心经营预算里？","standfirst":"Q2 的商业收入、TCV 与利润同时加速，这一点没有争议。还需要验证的是这笔支出的预算归属：创新预算会随周期收缩，核心经营预算会被保住。","whyItMatters":"上游算力支出早就能从几家公司的资本开支里读出来，应用层能不能反复拿到企业的经营预算，公开证据一直很薄。Palantir 是少数把这条链条两端都披露出来的样本：合同签了多少，收入确认了多少。它的定价方式又把增长久期推到研究中心。一家按 forward sales 定价的公司，容错来自增长还能持续多久；单季增速再高，也只解释其中一部分。","consensus":"美国商业收入增长 149%、TCV bookings 增长 153%、全年指引再次上调，这些已经在价格里。","differentiated":"增量信息来自三条序列能否继续同步：TCV bookings、确认收入、全年指引。TCV 记的是承诺额，多年期合同和签约时点都能让它单独走高，只有确认收入跟着走，采购和收入确认这两道关口才算真正穿过。第二个观察点是商业收入相对政府收入的位置，Q2 已经到约 94%，越过去意味着这家公司的收入结构被重写一次。","valuation":"估值只做企业价值敏感性。基数取公司自己的全年收入指引，增长和 sales multiple 都写进算式，读者可以重算。2026-08-05 当日经许可的企业价值和完全稀释股数不在手上，所以这里不陈述当日 forward P/S，也不给每股结论。","update":"v3.0 保留 2026-08-05 发布时点，asOf 更新至 2026-09-14，纳入 9 月回撤、TITAN 合同与 Q3 对账窗口。","evidenceClaimIds":["CL-PLTR-001","CL-PLTR-002","CL-PLTR-003","CL-PLTR-006","CL-PLTR-007"],"causalChain":[{"title":"AIP 接进业务流程","body":"Ontology 把数据、权限和动作放到同一层，模型输出落在具体决策上。","claimIds":["CL-PLTR-004"]},{"title":"预算类别改变","body":"TCV、bookings 与确认收入同步，才说明这笔钱通过了采购和收入确认。","claimIds":["CL-PLTR-002","CL-PLTR-004"]},{"title":"久期接受检验","body":"领先的合同指标一旦先减速，增长久期假设就要下修。","claimIds":["CL-PLTR-005"]}],"riskClaimIds":["CL-PLTR-005"],"forwardTestIds":["FAL-PLTR-001","FAL-PLTR-002"]},"en":{"locale":"en","siblingLocale":"zh-CN","title":"Palantir: Hard commercial proof, zero valuation slack","question":"Are U.S. commercial customers funding AIP from innovation budgets or from the core operating plan?","standfirst":"Commercial revenue, TCV and margin accelerated together in Q2, and that much is settled. What still needs proving is where the money sits. Innovation budgets get cut in a downturn. Operating budgets get defended.","whyItMatters":"Capital-expenditure disclosure long ago made upstream AI spend easy to observe. Evidence that the application layer can repeatedly win enterprise operating budgets is far thinner. Palantir is unusual in disclosing both ends of that chain: what was contracted and what was recognized. It also prices off forward sales, which puts duration at the center of the work. For a company valued that way, the margin for error lives in how long growth lasts, and a single quarter's rate explains only part of it.","consensus":"149% U.S. commercial growth, 153% TCV-bookings growth and another guidance raise are already in the price.","differentiated":"The information gain comes from whether three series keep moving together: TCV bookings, recognized revenue and full-year guidance. TCV records committed value, and multi-year terms or signing timing can lift it on their own. Recognition is what confirms the spend cleared both procurement and the revenue standard. The second marker is commercial revenue against government revenue, already near 94% in Q2. Crossing it would rewrite the company's revenue mix.","valuation":"Valuation here stops at enterprise-value sensitivity. The base is the company's own full-year guidance, with growth and the sales multiple written into arithmetic a reader can rebuild. Licensed point-in-time enterprise value and fully diluted share count for August 5 were not available, so no observed forward-sales multiple and no per-share conclusion appear.","update":"Version 3.0 keeps the August 5 publication date, moves asOf to September 14, and adds the September pullback, the TITAN award and the Q3 reconciliation window.","evidenceClaimIds":["CL-PLTR-001","CL-PLTR-002","CL-PLTR-003","CL-PLTR-006","CL-PLTR-007"],"causalChain":[{"title":"AIP lands inside the workflow","body":"Ontology puts data, permissions and actions in one layer, so model output attaches to a specific decision.","claimIds":["CL-PLTR-004"]},{"title":"The budget line changes","body":"Only when TCV, bookings and recognized revenue move together has the spend cleared procurement and recognition.","claimIds":["CL-PLTR-002","CL-PLTR-004"]},{"title":"Duration gets tested","body":"If the leading contract indicators slow first, the growth-duration assumption has to come down.","claimIds":["CL-PLTR-005"]}],"riskClaimIds":["CL-PLTR-005"],"forwardTestIds":["FAL-PLTR-001","FAL-PLTR-002"]}},"dataGaps":[{"zh-CN":"2026-08-05 当日经许可的 point-in-time 企业价值和完全稀释股数不可得，因此本对象不陈述当日 forward P/S，也不给每股价值；情景里的 sales multiple 都是外生假设。","en":"Licensed point-in-time enterprise value and fully diluted share count for August 5 were unavailable, so the object states no observed forward-sales multiple and no per-share value. Every sales multiple in the scenarios is an exogenous assumption."},{"zh-CN":"Q3 2026 财报确切日期与财报前卖方一致预期分布不可得，增速对指引的比较以公司自身口径为准。","en":"The exact Q3 2026 earnings date and pre-earnings sell-side consensus distribution are unavailable; growth comparisons use company guidance only."}]}}